STRATA Skin Sciences, Inc.
General ticker "SSKN" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $28.7M (TTM average)
STRATA Skin Sciences, Inc. does not follow the US Stock Market performance with the rate: -37.0%.
Estimated limits based on current volatility of 3.6%: low 1.37$, high 1.47$
Factors to consider:
- Total employees count: 28 as of 2005
- China accounted for 10.0% of revenue in the fiscal year ended 2023-12-31
- US accounted for 69.0% of revenue in the fiscal year ended 2023-12-31
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.39$, 4.23$]
- 2025-12-31 to 2026-12-31 estimated range: [1.19$, 3.63$]
Financial Metrics affecting the SSKN estimates:
- Positive: with PPE of -1.1 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of 0.17 <= 0.33
- Positive: Interest expense per share per price, % of 1.89 <= 3.41
- Positive: -4.48 < Investing cash flow per share per price, % of -1.46
- Negative: Shareholder equity ratio, % of 13.75 <= 18.93
- Positive: Industry inventory ratio change (median), % of -1.44 <= -0.15
- Positive: Inventory ratio change, % of -1.15 <= -0.75
Short-term SSKN quotes
Long-term SSKN plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $36.16MM | $33.36MM | $33.56MM |
| Operating Expenses | $40.81MM | $41.96MM | $42.82MM |
| Operating Income | $-4.65MM | $-8.60MM | $-9.26MM |
| Non-Operating Income | $-0.84MM | $-2.32MM | $-1.00MM |
| Interest Expense | $0.93MM | $1.64MM | $2.11MM |
| R&D Expense | $1.03MM | $1.32MM | $0.88MM |
| Income(Loss) | $-5.49MM | $-10.92MM | $-10.26MM |
| Taxes | $0.06MM | $-0.09MM | $-0.17MM |
| Profit(Loss)* | $-5.55MM | $-10.83MM | $-10.09MM |
| Stockholders Equity | $21.83MM | $12.69MM | $4.97MM |
| Inventory | $5.55MM | $2.67MM | $2.25MM |
| Assets | $52.27MM | $42.02MM | $36.16MM |
| Operating Cash Flow | $-0.92MM | $-0.52MM | $0.19MM |
| Capital expenditure | $3.55MM | $5.02MM | $1.64MM |
| Investing Cash Flow | $-4.37MM | $-5.02MM | $-1.64MM |
| Financing Cash Flow | $-0.50MM | $6.86MM | $1.93MM |
| Earnings Per Share** | $-0.16 | $-0.31 | $-0.26 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.